A Message from the EULAR President 

Dear Friends,

I am very honoured to address you all in my new role as President of EULAR and extend my warmest greetings to all of you. EULAR has been a beacon of excellence in the field of Rheumatology since its establishment in 1947, earning a distinguished reputation as a non-profit organisation in the service for individuals with musculoskeletal disease in Europe and around the world.

As a new president, you are frequently faced with the question about “your” agenda for the elected term. While this question is flattering, it is important to state here that EULAR, by its growth and current size, has become a huge ocean cruiser: no single person will (and should!) create substantial deviations from this successful path. It has become more and more important to have a trusting and collegial leadership team where one presidency links into the agenda of the one before and paths the way for the one following. 

Read more

EULAR Strategy 2024 - 2028

EULAR has launched its new EULAR Strategy 2024 - 2028: Embracing a profound vision for a world where all rheumatic and musculoskeletal diseases (RMDs) are acknowledged, diagnosed and ultimately prevented or cured. 
This transformative strategy centres on EULAR's mission to reduce the impact of RMDs on individuals and societies alike by fostering education, awareness, optimal clinical care, prevention, and cutting-edge research in the field of RMDs. EULAR aims to pave the way towards effective global solutions for managing these conditions.

Read more

News from Societies

​EULAR is delighted to share Rheumatology-related news from other societies in our quest to improve the lives of people with rheumatic and musculoskeletal diseases.

  • ​The British Society for Rheumatology has published new guidelines for the treatment of rheumatic conditions during conception, pregnancy and breastfeeding.




Read more

EULAR Press Releases

The latest: 

  • Updated: RA Treatment Recommendations
  • Updated: RA Treatment Recommendations
  • Revised: ACR/EULAR Remission Criteria


Read more

EULAR Announces Measures to Support Ukraine 

EULAR has taken a series of decisions in view of Russia’s government attack on Ukraine

The European Alliance of Associations for Rheumatology, EULAR, strongly dissents Russia’s government attack on Ukraine, in violation of Ukraine’s sovereignty, territorial integrity, independence, and the welfare of its residents. As hospitals are being attacked and access to medical aid is interrupted, EULAR wants to respond to this humanitarian crisis and particularly support the Ukrainian people with rheumatic and musculoskeletal diseases (RMDs), who need urgent treatment and assistance.

Read more 

EULAR Recommendations

Read the latest:

  • EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
  • EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis